Reproductive Endocrinology Neuroendocrinology

Oral contraceptives and the serotonin 4 receptor: a molecular brain imaging study in healthy women

Larsen SV, Köhler-Forsberg K, Dam VH, Poulsen AS, Svarer C, Jensen PS, Knudsen GM, Fisher PM, Ozenne B, Frokjaer VG

Published October 2020 Acta Psychiatrica Scandinavica, 142(4), 294-306
DOI 10.1111/acps.13211 PMID 33314049 PMC PMC7586815

RRM Academy Synopsis

Healthy oral contraceptive users had less serotonin 4 receptor binding

In a brain imaging study of 53 healthy women, oral contraceptive users had 9–12% lower serotonin 4 receptor binding across the whole brain than non-users. Sixteen women used oral contraceptives. The authors call this a plausible molecular link to depression risk.

Key Findings

  • Across the brain, oral contraceptive users had 9–12% lower global serotonin 4 receptor binding potential than non-users (γ = −0.099, P = 0.0039).
  • Regional estimates of the oral contraceptive effect on binding potential ranged from −9.4% to −11.7%.
  • The gap was widest in the hippocampus, where binding was −12.8% (corrected P = 0.03; 95% CI [−21.0; −3.9]).
  • Analyses limited to scans from one PET scanner, and to those scans from women without familial risk for major depressive disorder, supported the same effect.
  • Women using a hormonal intrauterine device (n = 8) showed no statistically significant association with binding, in an analysis with clearly suboptimal power.

Interpretation

This cross-sectional imaging study scanned the brains of 53 healthy women at a single point in time. Oral contraceptive users showed lower serotonin 4 receptor binding throughout the brain, widest in the hippocampus. All participants were healthy, with no depression symptoms on standardized questionnaires. The authors propose this receptor pattern as a plausible molecular pathway linking oral contraceptives to depression risk. The findings support larger studies of this pathway.

RRM Context

Oral contraceptives are suppressive medications. The paper says they cut the ovaries' own hormone output and disrupt ovulation. The authors propose that lower binding reflects less receptor gene activity, perhaps tied to a dampened ovarian hormone state. Restorative reproductive medicine treats the ovulatory cycle as a vital sign and works to restore it.

Abstract

Objective

Sex steroid hormones potently shape brain functions, including those critical to maintain mental health such as serotonin signaling. Use of oral contraceptives (OCs) profoundly changes endogenous sex steroid hormone levels and dynamics. Recent register-based studies show that starting an OC is associated with increased risk of developing depression. Here, we investigate whether use of OCs in healthy women is associated with a marker of the serotonin system in terms of serotonin 4 receptor (5-HT4R) brain imaging.

Methods

[(11)C]SB207145-PET imaging data on 53 healthy women, of whom 16 used OCs, were available from the Cimbi database. We evaluated global effects of OC use on 5-HT4R binding in a latent variable model based on 5-HT4R binding across cortical and subcortical regions.

Results

We demonstrate that OC users have 9-12% lower global brain 5-HT4R binding potential compared to non-users. Univariate region-based analyses (pallidostriatum, caudate, hippocampus, amygdala, anterior cingulate cortex, and neocortex) supported the global effect of OC use with the largest difference present in the hippocampus (-12.8% (95% CI [-21.0; -3.9], P(corrected) = 0.03).

Conclusion

We show that women who use OCs have markedly lower brain 5-HT4R binding relative to non-users, which constitutes a plausible molecular link between OC use and increased risk of depressive episodes. We propose that this reflects a reduced 5-HT4R gene expression, possibly related to a blunted ovarian hormone state among OC users.

Topics

By this author

Related research

Reproductive Endocrinology › Neuroendocrinology › Hypothalamic Pituitary Axis · Contraception › Oral Contraceptives › Metabolic Effects
Søren Vinther Larsen, Vibe Gedso Frokjaer
S Larsen, V Frokjaer
PMID 33314049 33314049 DOI 10.1111/acps.13211 10.1111/acps.13211 Larsen et al. 2020, Larsen 2020